收藏切换
Research progress on pharmacological mechanism of Lycium barbarum polysaccharides in Alzheimer’s disease
收藏切换
YANG Haolin, HUANG Yating, ZHAO Ruomei, YOU Kexin, YIN Di, XU Anran, YANG Fei
Chinese Traditional and Herbal Drugs | 2025, 56(17) : 6439 - 6449
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(17): 6439-6449
Research progress on pharmacological mechanism of Lycium barbarum polysaccharides in Alzheimer’s disease
Full
YANG Haolin, HUANG Yating, ZHAO Ruomei, YOU Kexin, YIN Di, XU Anran, YANG Fei
Affiliations
About Author:
四川省基层卫生中心项目 (SWFZ24-Y-70); 南充市社会科学界联合会项目 (NC25B240); 川北医学院博士启动基金 (CBY23-QDA29)
doi: 10.7501/j.issn.0253-2670.2025.17.031
Outline
收藏切换
Alzheimer’s disease (AD) is a neurodegenerative disorder of the central nervous system characterized by progressive deterioration of learning and memory functions. With the intensification of population aging, the incidence of AD continues to rise annually, posing a significant public health threat. Currently, the pathogenesis of AD remains incompletely elucidated, and clinically effective treatments are still lacking. Traditional Chinese medicine (TCM), with its characteristic multi-component composition and multi-target activity, offers advantages in treating complex multifactorial diseases. Studies indicate that Lycium barbarum polysaccharide (LBP), the primary active component of Gouqizi (Lycii Fructus), exhibits promising therapeutic potential for AD through its effects including anti-inflammatory, anti-apoptotic, mitochondrial protective, and anti-oxidant properties and functions of inhibiting β-amyloid (Aβ) abnormal deposition and Tau protein hyperphosphorylation, regulating neurotransmitter, restoring synaptic plasticity, modulating the microbiota-gut-brain axis, and improving insulin resistance, contributing to AD prevention and treatment. This study analyzes the pharmacological mechanisms underlying LBP’s therapeutic effects in AD, providing a reference for future research on the prevention and treatment of AD by LBP.
Lycium barbarum polysaccharide  /  Alzheimer’s disease  /  amyloid β  /  Tau protein  /  neuroinflammation  /  insulin resistance
杨昊霖, 黄雅婷, 赵若梅, 游可欣, 尹迪, 徐安然, 杨飞. 枸杞多糖在阿尔茨海默病中药理作用机制研究进展. 中草药, 2025 , 56 (17) : 6439 -6449 . DOI: 10.7501/j.issn.0253-2670.2025.17.031
YANG Haolin, HUANG Yating, ZHAO Ruomei, YOU Kexin, YIN Di, XU Anran, YANG Fei. Research progress on pharmacological mechanism of Lycium barbarum polysaccharides in Alzheimer’s disease[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (17) : 6439 -6449 . DOI: 10.7501/j.issn.0253-2670.2025.17.031
Year 2025 volume 56 Issue 17
45
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.17.031
  • Receive Date:2025-04-03
  • Online Date:2026-11-12
Article Data
Affiliations
History
  • Received:2025-04-03
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.17.031
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT